Company / Operating Income per Share
Vera Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.91
FY2025
5-year range
-$4.91 / -$2.39
FY2021-FY2025
Trend
-62.5%
vs FY2024
Sector context
#169 of 201
Health Care
What the data says
Vera Therapeutics, Inc.'s operating income per share of $-4.91 is lower than 84% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 6 years, ranging from $-163.27 in FY2020 to $-2.39 in FY2023.
Based on SEC 10-K filings.
-4.91 in FY2025.
Declined from $-2.39 to $-4.91 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 201This company -$4.91 Sector average -$28.56
▼
+82.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 62.5% year-over-year.
- Ranks #169 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.91 | -62.5% |
| FY2024 | -$3.02 | -26.5% |
| FY2023 | -$2.39 | +30.2% |
| FY2022 | -$3.42 | -33.6% |
| FY2021 | -$2.56 | +98.4% |
| FY2020 | -$163.27 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026